The top life sciences startups to watch this year

FromBioSpace

Start listening View podcast show

The top life sciences startups to watch this year

FromBioSpace

ratings:

Length:

15 minutes

Released:

Jan 3, 2024

Format:

Podcast episode

Description

Welcome to 2024! This week we're discussing BioSpace's tenth annual list of the hottest new life sciences companies in the U.S. NextGen Class of 2024⁠ includes organizations that launched between September 2022 and September 2023 with a Series A funding.
BioSpace's Greg Slabodkin, Heather McKenzie and Tyler Patchen discuss.

Released:

Jan 3, 2024

Format:

Podcast episode

Titles in the series (46)

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

Skip carousel

Q3 earnings recap: winners, losers & surprises by BioSpace
18 min listen
Zepbound vs Wegovy: a two horse race by BioSpace
14 min listen
Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure by BioSpace
18 min listen
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA by BioSpace
21 min listen
Artificial Intelligence, Part 2: Human Interaction, Liability, and Patient Safety by BioSpace
17 min listen
Deals, Dupixent and GLP-1 drug shortages by BioSpace
17 min listen
The top life sciences startups to watch this year by BioSpace
15 min listen
Fast and furious evolution: how to ensure AI is catalyst for positive societal change with Microsoft and IQVIA by BioSpace
32 min listen
First ever CRISPR gene therapy approval: What happens next? by BioSpace
13 min listen
GLP-1 and ADC rollercoasters pick up speed by BioSpace
13 min listen
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior by BioSpace
17 min listen
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
45 min listen
Major FDA approvals for Vertex/CRISPR; bluebird gets black box warning and price scrutiny by BioSpace
17 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics by BioSpace
48 min listen
What VCs really think of the market right now with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
22 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
Optimistic, but for how long? Our big takeaways from #JPM2024 by BioSpace
14 min listen
Every move you make: biopharma industry under heavy scrutiny by BioSpace
16 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen
Iovance wins with Amtagvi and the ADC train chugs on by BioSpace
14 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen

More Episodes from BioSpace

Skip carousel

Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap by BioSpace
15 min listen
Women's Health: Where Politics and Science Meet by BioSpace
22 min listen
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird by BioSpace
12 min listen
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy by BioSpace
12 min listen
The IRA, BMS’ Big Cuts, First WHIM Approval by BioSpace
16 min listen
Where Do We Go From Here? The Future of Women's Health by BioSpace
22 min listen
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player by BioSpace
18 min listen
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages by BioSpace
20 min listen
It's a Design Problem: Women and Clinical Trials by BioSpace
20 min listen
Alphabet Soup: AACR and ACC Dominate Headlines This Week by BioSpace
17 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of Helping Patients? by BioSpace
22 min listen
Bayer’s sweeping executive cuts, Wegovy’s expanding reach by BioSpace
17 min listen
Money talk: Salary trends and raises by BioSpace
15 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The unintended consequences of small molecules by BioSpace
25 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen
The gap is where the pain is: Drug pricing and patient costs by BioSpace
20 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Iovance wins with Amtagvi and the ADC train chugs on by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Balancing act: Patient access and innovation by BioSpace
21 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
Optimistic, but for how long? Our big takeaways from #JPM2024 by BioSpace
14 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen

Related podcast episodes

Skip carousel

The Society for Integrative and Comparative Biology 2017 Annual Meeting: The Society for Integrative and Comparative Biology (SICB), an American Institute of Biological Sciences member society, fosters research, education, public awareness, and understanding of living organisms from molecules and cells to ecology and evolutio by BioScience Talks
31 min listen
Research Trends in Pediatric Critical Care Medicine: Current and Emerging Areas of Interest: In this World Shared Practice Forum podcast, Dr. … by OPENPediatrics
15 min listen
Medical Glass, Materials Science & the COVID Vaccine Supply Chain | Chris Weikart | #50 by Mind & Matter
58 min listen
61. Living in a Material World: Karl at Biofabricate 2024 by Grow Everything Biotech Podcast
36 min listen
May 24-26th, 2022 International Research Symposium on Animal Communication, with Barbara & Avantika, your Podcast Hosts by Animals & Us - Voices of a New Paradigm
15 min listen
The nightmare specter of designer bioweapons and the people trying to stop them by Riskgaming
34 min listen
Is CRISPR the New Sickle Cell Savior?: 2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients. by I AM BIO
25 min listen
Indiebio — Jun Axup, Director Of Science — World’s Largest Seed Bio-Technology Accelerator: IndieBio, located in San Francisco, is the world’s largest seed bio-technology accelerator and has funded 81 companies over their three-year history. Each company or start-up that they work with receives $250,000… by Finding Genius Podcast
24 min listen
A Conversation With Will Patrick of Culture Biosciences: In the world of computing, the ability to build new products and scale quickly is something that has come to be expected. Long-established toolsets enable innovators to invent, iterate and scale and get to market much more quickly than in the past. While by The Spoon Podcast
36 min listen
Should You Invest in Synthetic Biology Stocks? by The 7investing Podcast
36 min listen
Society for Integrative and Comparative Biology Annual Meeting Report: The Society for Integrative and Comparative Biology (SICB), an American Institute of Biological Sciences member society, fosters research, education, public awareness, and understanding of living organisms from molecules and cells to ecology and evolutio by BioScience Talks
40 min listen
Brockovich’s Deceptive Guardian Article: On December 6, 2018 environmental advocate Erin Brockovich published a high-profile opinion piece in The Guardian. The piece was laced with scientific inaccuracies and inflammatory rhetoric about glyphosate, indicating in no uncertain terms that it cause by Talking Biotech with Dr. Kevin Folta
18 min listen
The PR Week special edition, 10.15.2022: PRDecoded: Go behind the scenes of PRWeek’s conference in Chicago. by The PR Week
24 min listen
BD Develops New Monkeypox Test + FDA Authorizes COVID-19 Vaccines for Infants by Xtalks Life Science Podcast
26 min listen
The best of 2023!: Our picks for some of the best scientific interviews of the past 12 months by The Naked Scientists Podcast
55 min listen
How ‘New Science’ Is Changing Healthcare: If there’s one good thing that’s come from the pandemic, it’s this: Scientists and drug manufacturers came together in record time and with a shared purpose to create a safe and effective Covid-19 vaccine. In doing so, they set a precedent for medical advancements. So, where do we go from here? In this episode, we’ll talk about how biopharma companies can learn from last year’s disruption and harness what Accenture calls ‘New Science’ to rapidly discover and deliver revolutionary treatments and preparing for in the midst of regulatory and economic shifts. We’ll speak with Chris Gibson, C.E.O. and Co-Founder at Recursion; Stuart Henderson, Global Industry Lead — Life Sciences at Accenture; and David Coman, C.E.O at Science 37. by Built for Change
29 min listen
#25 What is the mycotoxin risk from harvest 2022? | Dr. Radka Borutova & Dr. Max Hawkins: Over the past few months, Alltech field teams have been actively working with their customers and partners to assess what is the mycotoxin risk attached to new crop grains and forages coming out of harvest 2022. In this episode, we are joined by Dr. ... by Mycotoxin Matters
25 min listen
Harnessing Biology to Address Global Challenges by The Bio Report
19 min listen
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022: In our first podcast episode of 2023, Back Bay’s strategic advisors summarize some of the most compelling healthcare development stories from 2022. by Back Bay Life Science Report
37 min listen
EP 91: 2022 Genetics Round-up with Dr Veera Rajagopal: In the final episode of The Genetics Podcast for 2022, we’re joined by Dr Veera Rajagopal, who is known as the ‘GWAS storyteller’ on Twitter for his prolific threads breaking down the latest findings in genetics. by The Genetics Podcast
90 min listen
Nature's Take: what's next for the preprint revolution: Nature editors take on the big topics that matter in science. by Nature Podcast
25 min listen
"CE: Announcing our 2023 Charity Ideas. Apply now!" by Steve Thompson & Charity Entrepreneurship by EA Forum Podcast (Curated & popular)
27 min listen
School Me; The Bipartisan Buzz, The Construction User 2.0; It’s Time! Live!; The Workers’ Speculative Society: On today’s show: Battling educator stress; kicking off 2024; innovation and ConTech; flight attendants raise the bar, and…extrapolation, speculation, fabulation; Steven Shaviro on the work of science fiction. This week’s featured shows are School Me,... by Labor Radio-Podcast Weekly
31 min listen
Communities, COVID and credit: the state of science collaborations: This week, Nature has a special issue on collaborations, looking at the benefits to science and society that working together can bring. In this collaboration-themed episode (produced jointly with the Nature Podcast and Working Scient... by Working Scientist
30 min listen
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah by Business Of Biotech
75 min listen
All About Synthetic Biology: With the field of synthetic biology -- which involves designing and engineering organisms to specific purposes -- exploding and driving both innovation and real-world impact from drug development to manufacturing and more, how did we get here? This episode digs deep with one of the pioneers of the synbio field. by a16z Podcast
36 min listen
COVID-19 Pandemic Anniversary + Cancer Biotech Acquisitions by Xtalks Life Science Podcast
40 min listen
Interview with Stephanie Willerth, Bioprinting Brain and Axolotl Biosciences by The Lattice (Official 3DHEALS Podcast)
23 min listen
The Meaning of Children: Competing Narratives by The Bioethics Podcast
54 min listen
Seth Berkley: Planning for the Largest Vaccine Rollout in History: For our first episode of Pandemic Planet, we are joined by Seth Berkley, CEO of Gavi, the Vaccine Alliance. by Pandemic Planet
25 min listen

Discover this podcast and so much more

The top life sciences startups to watch this year

The top life sciences startups to watch this year

Description

Titles in the series (46)

More Episodes from BioSpace

Related podcast episodes